BCL2-Related Ovarian Killer (BOK) (N-Term) Peptide
BOK
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BOK products
- BOK (BCL2-Related Ovarian Killer (BOK))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- AAEIMDAFDR SPTDKELVAQ AKALGREYVH ARLLRAGLSW SAPERAAPVP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BOK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BOK (BCL2-Related Ovarian Killer (BOK))
- Background
-
The protein encoded by this gene belongs to the BCL2 family, members of which form homo- or heterodimers, and act as anti- or proapoptotic regulators that are involved in a wide variety of cellular processes. Studies in rat show that this protein has restricted expression in reproductive tissues, interacts strongly with some antiapoptotic BCL2 proteins, not at all with proapoptotic BCL2 proteins, and induces apoptosis in transfected cells. Thus, this protein represents a proapoptotic member of the BCL2 family.
Alias Symbols: BOK,BCL2L9,
Protein Size: 212 - Gene ID
- 666
- NCBI Accession
- XP_005247094
- UniProt
- Q9UMX3
-
You are here:
